• Gujarat
  • India
  • World
  • Sports
  • Entertainment
  • Education
  • Lifestyle
    • Fashion
    • Recipe
    • Travel
    • Health
  • Others
    • Business
    • Technology
    • Horoscope
  • ગુજરાતી
  • Gujarat
  • India
  • World
  • Sports
  • Entertainment
  • Education
  • Lifestyle
    • Fashion
    • Recipe
    • Travel
    • Health
  • Others
    • Business
    • Technology
    • Horoscope
  • ગુજરાતી
Authors

Powered by

US FDA

US FDA mandates label updates on CAR-T cancer therapies

US FDA mandates label updates on CAR-T cancer therapies

By Connect Gujarat Desk 19 Apr 2024
US FDA finds new manufacturing lapses at Eli Lilly plant Health & Fitness

US FDA finds new manufacturing lapses at Eli Lilly plant

Lilly said in a statement that tirzepatide, the active ingredient in Mounjaro and Zepbound, was not manufactured at the Branchburg plant

By Connect Gujarat Desk 20 Jan 2024
Share
Twitter Share Whatsapp LinkedIn
US FDA approves Pfizer's blood cancer therapy Health & Fitness

US FDA approves Pfizer's blood cancer therapy

Elrexfio will be sold in the United States at a list price of $7,556 and $13,051 for the 44 mg and the 76 mg vial, respectively, Pfizer said

By Connect Gujarat Desk 15 Aug 2023
Share
Twitter Share Whatsapp LinkedIn
US FDA declines to approve Amneal Pharma's Parkinson's drug Health & Fitness

US FDA declines to approve Amneal Pharma's Parkinson's drug

Shares of Amneal Pharmaceuticals fell 13.1% to $2.7 in choppy after-market trading

By Connect Gujarat Desk 04 Jul 2023
Share
Twitter Share Whatsapp LinkedIn
US FDA approves Pfizer's hair loss drug Health & Fitness

US FDA approves Pfizer's hair loss drug

The FDA's decision makes Litfulo the first to be allowed for the treatment of the condition in adolescents

By Connect Gujarat Desk 24 Jun 2023
Share
Twitter Share Whatsapp LinkedIn
US FDA halts Sun Pharma's trials on dermatological drug Health & Fitness

US FDA halts Sun Pharma's trials on dermatological drug

The company said it would work closely with the US FDA to address the agency's concerns, which the drugmaker expected to be communicated within the next 30 days

By Connect Gujarat Desk 02 May 2023
Share
Twitter Share Whatsapp LinkedIn
Web Stories
No more pages
Powered by


Subscribe to our Newsletter!




Powered by